ClariVest Asset Management’s Enzo Biochem, Inc. ENZ Stock Holding History

ClariVest Asset Management’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-128,827	Closed	-$358K	–	790
2018 Q4	$358K	Sell	128,827 -262,728	-67%	-$861K	0.01%	486
2018 Q3	$1.61M	Buy	391,555 +10,901	+3%	+$49.5K	0.03%	354
2018 Q2	$1.98M	Sell	380,654 -22,643	-6%	-$138K	0.03%	347
2018 Q1	$2.21M	Sell	403,297 -80,116	-17%	-$564K	0.04%	328
2017 Q4	$3.94M	Buy	483,413 +68,515	+17%	+$654K	0.07%	225
2017 Q3	$4.34M	Buy	414,898 +148,578	+56%	+$1.65M	0.1%	187
2017 Q2	$2.94M	Buy	266,320 +64,543	+32%	+$601K	0.07%	229
2017 Q1	$1.69M	Sell	201,777 -80,080	-28%	-$564K	0.04%	293
2016 Q4	$1.96M	Buy	281,857 +16,806	+6%	+$107K	0.05%	267
2016 Q3	$1.35M	Sell	265,051 -452	-0.2%	-$2.7K	0.04%	267
2016 Q2	$1.58M	Buy	265,503 +11,300	+4%	+$62.7K	0.05%	247
2016 Q1	$1.16M	Buy	254,203 +2,200	+0.9%	+$9.79K	0.04%	267
2015 Q4	$1.14M	Buy	252,003 +38,251	+18%	+$162K	0.03%	276
2015 Q3	$679K	Buy	213,752 +960	+0.5%	+$2.91K	0.02%	304
2015 Q2	$644K	Buy	212,792 +768	+0.4%	+$2.16K	0.02%	320
2015 Q1	$624K	Buy	212,024 +1,600	+0.8%	+$5.24K	0.02%	325
2014 Q4	$935K	Sell	210,424 -9,100	-4%	-$43.4K	0.03%	236
2014 Q3	$1.13M	Buy	219,524 +172,160	+363%	+$919K	0.04%	223
2014 Q2	$249K	Buy	47,364 +45,481	+2,415%	+$197K	0.01%	344
2014 Q1	$8K	Buy	+1,883	New	+$6.45K	﹤0.01%	491

Other funds holding ENZ

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ClariVest Asset Management's ENZ Position: Q1 2019 in Review

ClariVest Asset Management sold out of Enzo Biochem, Inc. (ENZ) in Q1 2019, closing a stake of 128,827 shares — an estimated $358K sold.

ClariVest Asset Management first reported a position in ENZ in Q1 2014 and held it in 20 quarters. The position peaked at $4.34M in Q3 2017. 85 funds tracked by Wall St. Rank hold ENZ as of Q1 2019.

ClariVest Asset Management reported no remaining Enzo Biochem, Inc. position as of Q1 2019 after selling out during the quarter.
ClariVest Asset Management sold 128,827 Enzo Biochem, Inc. shares in Q1 2019, an estimated $358K.
ClariVest Asset Management first reported a position in Enzo Biochem, Inc. in Q1 2014 and held it in 20 quarters.
ClariVest Asset Management's Enzo Biochem, Inc. position peaked at $4.34M in Q3 2017.
85 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2019.

Based on ClariVest Asset Management's 13F filing for Q1 2019, filed 13 May 2019.